Annual SHOT Report 2011
| dc.contributor.author | Serious Hazards of Transfusion (SHOT) | |
| dc.date.accessioned | 2023-03-04T14:11:20Z | |
| dc.date.available | 2023-03-04T14:11:20Z | |
| dc.identifier.citation | Serious Hazards of Transfusion (SHOT) Working Expert Group and Writing Group. (2012). Annual SHOT Report 2011. Pgs 1-188. | en_US |
| dc.identifier.issn | 9780955864841 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12417/1363 | |
| dc.description | SHOT is affiliated to the Royal College of Pathologists | en_US |
| dc.description.abstract | Transfusion of blood components in the UK remains remarkably safe, with the risk of death 0.0027 and risk of major morbidity 0.0396 per 1000 components issued respectively. However, the level of error in the transfusion process is a cause for concern, indicating the need for continued education, which should underpin competency assessment, and vigilance. Checklists are very useful to ensure all the steps of a process have been completed. Any unexpected transfusion reactions must be promptly recognised and treated and continue to be reported to ensure patient safety, particularly with the advent of new products and changing policies in relation to CMV screening. All staff involved in transfusion should remain aware that they have a duty of care to report adverse events which potentially or actually affect patient safety. | |
| dc.language.iso | en | en_US |
| dc.subject | Serious Hazards of Transfusion | en_US |
| dc.subject | Blood Transfusion | en_US |
| dc.subject | Transfusion Reaction | en_US |
| dc.title | Annual SHOT Report 2011 | en_US |
| dcterms.dateAccepted | 2022-10-17 | |
| rioxxterms.version | NA | en_US |
| rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | en_US |
| rioxxterms.type | Technical Report | en_US |
| refterms.dateFOA | 2023-03-04T14:11:21Z | |
| refterms.panel | Unspecified | en_US |
| html.description.abstract | Transfusion of blood components in the UK remains remarkably safe, with the risk of death 0.0027 and risk of major morbidity 0.0396 per 1000 components issued respectively. However, the level of error in the transfusion process is a cause for concern, indicating the need for continued education, which should underpin competency assessment, and vigilance. Checklists are very useful to ensure all the steps of a process have been completed. Any unexpected transfusion reactions must be promptly recognised and treated and continue to be reported to ensure patient safety, particularly with the advent of new products and changing policies in relation to CMV screening. All staff involved in transfusion should remain aware that they have a duty of care to report adverse events which potentially or actually affect patient safety. | en_US |
